How Health Data Drive Innovation. Panel moderated by Emil Syundyukov / Longenesis

Health data innovation in the Nordic and Baltic countries: opportunities, challenges, and the role of trust, consent, and cross-border collaboration in driving healthcare innovation and research.

Key takeaways
  • Health data is a crucial driver of innovation in the healthcare sector, and Nordic countries have a unique advantage in this area.
  • Baltic countries like Estonia and Latvia can learn from Sweden, Finland, and Denmark in terms of data collection and utilization.
  • Consumers are increasingly willing to share their health data, but trust issues remain a challenge, and consent is a key aspect to consider.
  • Harmonizing data curation and creating a systematic approach to data management is essential for innovation.
  • Collaboration across borders can lead to better health outcomes, and exchanging best practices can facilitate skills and knowledge sharing.
  • Data-driven companies are struggling to access high-quality data, and obstacles in data collection and utilization need to be addressed.
  • European Health Data Space (EHDS) regulations can either limit or enable innovation, depending on their implementation.
  • Health data can be used for precision medicine, rare disease research, and pharmacovigilance, among other areas.
  • Data sharing between Nordic countries and the Baltics can be beneficial for healthcare innovation and research, and addressing concerns about data protection is essential.
  • Startups need support and access to data to innovate and grow the health tech industry.
  • The importance of consent and trust in data sharing should not be underestimated.
  • Harmonizing data curation and creating a systematic approach to data management is essential for innovation and data utilization.
  • Cross-border collaboration can lead to better health outcomes, and exchanging best practices can facilitate skills and knowledge sharing.